Skip to main content
Caplight Logo









Cellectric Biosciences

Cellectric Biosciences

Private
ViennaHealthcare & Life Scienceshttps://cellectric.com

Last Round

Seed

Aug 6, 2024

Total Funding Raised

$1.07M

Company Overview

Cellectric Biosciences is a biotech company developing a platform for automated cell manipulation using electric fields for life science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription

AI Layer

Non-AI

Keywords

sepsis diagnosticspathogen isolationsample preparationelectrodynamic cell manipulationrapid diagnosticssample preplab automationcell-selective lysisinfection diagnosticspathogen detectiondiagnostics platformclinical diagnosticsbiotech equipmentdiagnostic consumableslife sciences toolsrapid Dx

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellectric Biosciences Comparables

Compare Cellectric Biosciences with similar companies based on industry and business-model similarity.

Cellectric Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Micronbrane Medical
82%
Avails Medical
70%
Covirabio GmbH
69%

Cellectric Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 6, 2024
GrantJun 13, 2024
Pre SeedFeb 21, 2022

Cellectric Biosciences Investors

Notable investors and investment history

Cellectric Biosciences investors
InvestorRounds
Austria WirtschaftsserviceGrant
FFG Austrian Research Promotion AgencyGrant
xista science venturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    RUO Device for selective cell lysis has prototypes.

  • Sep 30, 2025

    Developing direct-from-blood application for sepsis diagnostics with Gradientech.

Cellectric Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellectric Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellectric Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range19
Year Founded2021
Last FundingAug 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?